These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


252 related items for PubMed ID: 16995478

  • 1. Preoperative IL-2 immunotherapy enhances tumor infiltrating lymphocytes (TILs) in gastric cancer patients.
    Romano F, Cesana G, Caprotti R, Bovo G, Uggeri F, Piacentini MG, Crippa S, Uggeri F.
    Hepatogastroenterology; 2006; 53(70):634-8. PubMed ID: 16995478
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Phase-II randomized study of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F, Piacentini MG, Franciosi C, Caprotti R, De Fina S, Cesana G, Uggeri F, Conti M, Uggeri F.
    Hepatogastroenterology; 2004; 51(60):1872-6. PubMed ID: 15532847
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Radical surgery does not recover immunodeficiency associated with gastric cancer.
    Romano F, Caprotti R, Bravo AF, Conti M, Colombo G, Piacentini G, Uggeri F, Uggeri F.
    J Exp Clin Cancer Res; 2003 Jun; 22(2):179-83. PubMed ID: 12866567
    [Abstract] [Full Text] [Related]

  • 6. [Effects of auto-tumor infiltrating lymphocytes induced by interleukin (IL)-12 with IL-2 on patients of primary hepatic carcinoma].
    Zhang YX, Wang XY, Liu JB, Zhang SQ, Chen YR.
    Zhonghua Yi Xue Za Zhi; 2008 Apr 08; 88(14):973-6. PubMed ID: 18756970
    [Abstract] [Full Text] [Related]

  • 7. Preoperative interleukin-2 immunotherapy in pancreatic cancer: preliminary results.
    Angelini C, Bovo G, Muselli P, Mussi C, Crippa S, Caprotti R, Uggeri F.
    Hepatogastroenterology; 2006 Apr 08; 53(67):141-4. PubMed ID: 16506394
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer.
    Lu P, Zhu XQ, Xu ZL, Zhou Q, Zhang J, Wu F.
    Surgery; 2009 Mar 08; 145(3):286-93. PubMed ID: 19231581
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. IGF-1 and IGF-1BP3 in gastric adenocarcinoma. Preliminary study.
    Franciosi CM, Piacentini MG, Conti M, Romano F, Musco F, Caprotti R, Rovelli F, Uggeri F.
    Hepatogastroenterology; 2003 Mar 08; 50(49):297-300. PubMed ID: 12630045
    [Abstract] [Full Text] [Related]

  • 16. Neoadjuvant immunotherapy of oral squamous cell carcinoma modulates intratumoral CD4/CD8 ratio and tumor microenvironment: a multicenter phase II clinical trial.
    Tímár J, Ladányi A, Forster-Horváth C, Lukits J, Döme B, Remenár E, Godény M, Kásler M, Bencsik B, Répássy G, Szabó G, Velich N, Suba Z, Elo J, Balatoni Z, Pócza K, Zemplén B, Chretien P, Talor E.
    J Clin Oncol; 2005 May 20; 23(15):3421-32. PubMed ID: 15908653
    [Abstract] [Full Text] [Related]

  • 17. Effect of pre-operative short course famotidine on tumor infiltrating lymphocytes in colorectal cancer: a double blind, placebo controlled, prospective randomized study.
    Kapoor S, Pal S, Sahni P, Dattagupta S, Kanti Chattopadhyay T.
    J Surg Res; 2005 Dec 20; 129(2):172-5. PubMed ID: 15882879
    [Abstract] [Full Text] [Related]

  • 18. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.
    Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, Xu Y, Li YW, Tang ZY.
    J Clin Oncol; 2007 Jun 20; 25(18):2586-93. PubMed ID: 17577038
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis.
    Gardini A, Ercolani G, Riccobon A, Ravaioli M, Ridolfi L, Flamini E, Ridolfi R, Grazi GL, Cavallari A, Amadori D.
    J Surg Oncol; 2004 Jul 15; 87(1):46-52. PubMed ID: 15221919
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.